BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Rating) shares hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $2.96 and last traded at $2.84, with a volume of 6830 shares traded. The stock had previously closed at $2.85.

BioRestorative Therapies Stock Performance

The firm has a market capitalization of $4.66 billion, a P/E ratio of -6.56 and a beta of 102.36. The stock has a 50-day moving average of $3.07 and a 200 day moving average of $3.17.

About BioRestorative Therapies

(Get Rating)

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.

Further Reading

• Get a free copy of the StockNews.com research report on BioRestorative Therapies (BRTXQ)
• The Top Three Stocks Analysts Say To Buy
• Can Dick's Sporting Goods Stock Score Another Win In Q4?
• Yum! Brands Looks Tasty in 2023
• Why Did Immutep Ltd Stock Soar Recently?
• 3 Industrial Stocks to Help Build Your 2023 Watchlist

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.